The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill

MLA

Jennifer M. Knight, et al. “The IL-6 Antagonist Tocilizumab Is Associated with Worse Depression and Related Symptoms in the Medically Ill.” Translational Psychiatry, vol. 11, no. 1, Jan. 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41398-020-01164-y.

APA

Jennifer M. Knight, Erin S. Costanzo, Suraj Singh, Ziyan Yin, Aniko Szabo, Deepa S. Pawar, Cecilia J. Hillard, J. Douglas Rizzo, Anita D’Souza, Marcelo Pasquini, Christopher L. Coe, Michael R. Irwin, Charles L. Raison, & William R. Drobyski. (2021). The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill. Translational Psychiatry, 11(1), 1–9. https://doi.org/10.1038/s41398-020-01164-y

Chicago

Jennifer M. Knight, Erin S. Costanzo, Suraj Singh, Ziyan Yin, Aniko Szabo, Deepa S. Pawar, Cecilia J. Hillard, et al. 2021. “The IL-6 Antagonist Tocilizumab Is Associated with Worse Depression and Related Symptoms in the Medically Ill.” Translational Psychiatry 11 (1): 1–9. doi:10.1038/s41398-020-01164-y.